Doxazosin - NDC Database (Page 13)
288 records found
Start a Discussion
68382-783 Aug 31, 2017
Doxazosin 1 mg Oral Tablet by Zydus Pharmaceuticals (Usa) Inc.
68382-784 Aug 31, 2017
Doxazosin 2 mg Oral Tablet by Zydus Pharmaceuticals (Usa) Inc.
68382-785 Aug 31, 2017
Doxazosin 4 mg Oral Tablet by Zydus Pharmaceuticals (Usa) Inc.
68382-786 Aug 31, 2017
Doxazosin 8 mg Oral Tablet by Zydus Pharmaceuticals (Usa) Inc.
68788-7149 Apr 23, 2018
Doxazosin 4 mg Oral Tablet by Preferred Pharmaceuticals Inc.
68788-7328 Mar 12, 2019
Doxazosin 2 mg Oral Tablet by Preferred Pharmaceuticals Inc.
68788-8412 Apr 06, 2023
Doxazosin 4 mg Oral Tablet by Preferred Pharmaceuticals Inc.
68788-8422 Apr 13, 2023
Doxazosin 2 mg Oral Tablet by Preferred Pharmaceuticals Inc.
70518-0184 Jan 27, 2017
Doxazosin Mesylate 2 mg Oral Tablet by Remedyrepack Inc.
70518-0398 Apr 04, 2017
Doxazosin Mesylate 4 mg Oral Tablet by Remedyrepack Inc.
70518-1560 Oct 19, 2018
Doxazosin 2 mg Oral Tablet by Remedyrepack Inc.
70518-1804 Jan 17, 2019
Doxazosin 4 mg Oral Tablet by Remedyrepack Inc.
70518-2183 Jul 02, 2019
Doxazosin 1 mg Oral Tablet by Remedyrepack Inc.
70518-3667 Mar 01, 2023
Doxazosin 2 mg Oral Tablet by Remedyrepack Inc.
70518-3965 Dec 17, 2023
Doxazosin 2 mg Oral Tablet by Remedyrepack Inc.
70518-4031 Feb 28, 2024
Doxazosin 4 mg Oral Tablet by Remedyrepack Inc.
70771-1112 Aug 31, 2017
Doxazosin 1 mg Oral Tablet by Cadila Healthcare Limited
70771-1113 Aug 31, 2017
Doxazosin 2 mg Oral Tablet by Cadila Healthcare Limited
70771-1114 Aug 31, 2017
Doxazosin 4 mg Oral Tablet by Cadila Healthcare Limited
70771-1115 Aug 31, 2017
Doxazosin 8 mg Oral Tablet by Cadila Healthcare Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us .
